Annals of vascular surgery · 2024
Low-Profile Minos TM Stent Graft System for Endovascular Abdominal Aorta Aneurysm Repair-Early and Late Outcomes in Elective and Emergent Situations.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Karaolanis Georgios I, Hadjis Demetrios, Karakosta Agathi, Bekas Nikolaos, Tatsis Vasileios, Tzimas Petros, Mitsis Michail, Peroulis Michail
Аннотация
BACKGROUND: The aim of the study was to present the results of a novel abdominal stent graft for patients with abdominal aortic aneurysm (AAA), through 2-year follow-up.
METHODS: A single-center retrospective review with prospectively collected data was performed to assess the safety and effectiveness of the Minos Abdominal stent device for treating AAAs. We estimated technical success rate, in-hospital and 30-day mortality, and mortality at the end of follow-up as well as complication and reintervention rate in our study cohort. Follow-up imaging assessments consisted of computed tomography angiography at 1 and 6 months and yearly thereafter.
RESULTS: A total of 52 patients (92% males; mean age, 74 ± 6 years) were enrolled with Minos Abdominal stent device from July 2020 until September 2023. Thirty one (60%) patients were asymptomatic while 21 (40%) were symptomatic. The technical success of the endovascular aortic repair was 95% (49 of 52 patients). In 5% (3 of 52) of the cases, cannulation of the contralateral limb was unsuccessful and was converted to aorto-uni-iliac graft. Two (4%) aortic related death were recorded during the 30-day period. The major adverse event rate was 3.8%. The overall mean follow-up was 30 ± 6 months; no aorta-related deaths or graft related complications were observed. Sac shrinkage (>5 mm) has been observed in 70% of patients.
CONCLUSIONS: Minos endoprosthesis seems to be safe, effective, and durable for treating AAA either in elective or emergent situations.
METHODS: A single-center retrospective review with prospectively collected data was performed to assess the safety and effectiveness of the Minos Abdominal stent device for treating AAAs. We estimated technical success rate, in-hospital and 30-day mortality, and mortality at the end of follow-up as well as complication and reintervention rate in our study cohort. Follow-up imaging assessments consisted of computed tomography angiography at 1 and 6 months and yearly thereafter.
RESULTS: A total of 52 patients (92% males; mean age, 74 ± 6 years) were enrolled with Minos Abdominal stent device from July 2020 until September 2023. Thirty one (60%) patients were asymptomatic while 21 (40%) were symptomatic. The technical success of the endovascular aortic repair was 95% (49 of 52 patients). In 5% (3 of 52) of the cases, cannulation of the contralateral limb was unsuccessful and was converted to aorto-uni-iliac graft. Two (4%) aortic related death were recorded during the 30-day period. The major adverse event rate was 3.8%. The overall mean follow-up was 30 ± 6 months; no aorta-related deaths or graft related complications were observed. Sac shrinkage (>5 mm) has been observed in 70% of patients.
CONCLUSIONS: Minos endoprosthesis seems to be safe, effective, and durable for treating AAA either in elective or emergent situations.
Предметные рубрики MeSH
HumansAortic Aneurysm, AbdominalMaleEndovascular ProceduresAgedFemaleRetrospective StudiesBlood Vessel ProsthesisBlood Vessel Prosthesis ImplantationTime FactorsStentsTreatment OutcomeProsthesis DesignElective Surgical ProceduresAged, 80 and overRisk FactorsPostoperative ComplicationsHospital MortalityEmergenciesMitochondria Associated Membranes